Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Nov 1, 2024 | Buy | 36,500 | $1 | $37,000 |
| Chong Ngai Hang Victor | Jun 24, 2024 | Buy | 23,500 | $1.06 | $25,000 |
| YERXA BENJAMIN R | May 15, 2024 | Buy | 7,813 | $1.31 | $10,000 |
| Gibney Anthony S | Apr 18, 2024 | Buy | 93,290 | $1.3 | $120,000 |
| Gibney Anthony S | Apr 17, 2024 | Buy | 6,710 | $1.25 | $8,400 |
| Chong Ngai Hang Victor | Mar 20, 2024 | Buy | 30,000 | $1.6 | $48,000 |
| LASEZKAY GEORGE M | Jan 19, 2024 | Sell | 18,000 | $1.27 | $23,000 |
| Deignan Charles A. | Jan 19, 2024 | Sell | 12,900 | $1.28 | $17,000 |
| WHITMORE BRADFORD T | Nov 1, 2023 | Buy | 64,366 | $0.7442 | $48,000 |
| WHITMORE BRADFORD T | Oct 31, 2023 | Buy | 70,812 | $0.7278 | $52,000 |
| WHITMORE BRADFORD T | Oct 30, 2023 | Buy | 600 | $0.685 | $410 |
| Hutson Nancy J | Oct 3, 2023 | Buy | 10,000 | $0.86 | $8,600 |
| Thorp Clay | Sep 25, 2023 | Buy | 10,000 | $0.86 | $8,600 |
| Ciulla Thomas | Jan 20, 2023 | Sell | 13,700 | $1.47 | $20,000 |
| LASEZKAY GEORGE M | Jan 19, 2023 | Sell | 20,030 | $1.46 | $29,000 |
| Deignan Charles A. | Jan 19, 2023 | Sell | 14,030 | $1.5 | $21,000 |
| Ciulla Thomas | Jan 10, 2023 | Sell | 2,170 | $1.62 | $3,500 |
What's the latest insider transaction for Clearside Biomedical?
The most recent insider transaction for Clearside Biomedical was conducted by Chong Ngai Hang Victor, who sold 36,500 shares on November 1, 2024 at a price of $1.00 per share.
Which insider bought the most CLSD stock over the last two years?
Gibney Anthony S has bought the most CLSD stock in the last 2 years, with a total value of $130,000.
Which insider has sold the most CLSD stock over the last two years?
LASEZKAY GEORGE M has sold the most CLSD stock in the last 2 years, with a total value of $52,000.
What is the total value of insider transactions for Clearside Biomedical (CLSD) in the last 2 years?
According to our estimates, the total value of insider transactions for Clearside Biomedical in the last 2 years is positive, amounting to $250,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Clearside Biomedical's market confidence?
Over the last 2 years, insider transactions for Clearside Biomedical have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
